Saturday, May 31, 2025

Latest

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today under the symbol “INAB”. The firm’s initial public offering is looking to raise US$40.0 million and is expected to close on August 3, 2021.

The offering consists of 4,000,000 common shares selling at US$10.00 per share. The company intends to use the proceeds of its offering on advancing the development of its two lead product candidates in T-cell therapies for treating cancer.

The company granted a 30-day over-allotment option to purchase additional 600,000 common shares at the same IPO price. B. Riley Securities, Inc. is acting as the sole bookrunner for the said offering.

The New York-based biotech company is focused on developing and commercializing gamma-delta T cells to treat cancer patients. The firm reported US$8.6 million net loss in 2020 and an approximately US$15 million cash balance as of March 31, 2021


Information for this briefing was found via Edgar and IN8bio. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the...

Tuesday, July 6, 2021, 11:20:00 AM

Tech SPAC Athena Technology Acquisition II Looks To Raise US$250 Million In IPO

Blank check company Athena Technology Acquisition Corp. II (NYSE: ATEK.U) went public today on the...

Friday, December 10, 2021, 02:11:00 PM

OLX Founder-Led Tech SPAC Global Technology Acquisition Closes US$200.0 Million IPO

Special purpose acquisition company Global Technology Acquisition Corp. I (Nasdaq: GTACU) closed on Monday its...

Tuesday, October 26, 2021, 02:07:00 PM

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on...

Saturday, May 21, 2022, 05:12:00 PM

Edtech Firm Genius Group Prices US$19.6 Million IPO

Edtech and education group Genius Group Limited (NYSE: GNS) began trading on the New York...

Tuesday, April 12, 2022, 02:19:00 PM